The invention relates to compounds of formula (I): or a salt or solvate thereof, wherein the variables are as described herein. Compounds of formula (I) and pharmaceutical compositions thereof are antagonists of toll-like receptors such as TLR7, TLR8 and/or TLR9 that are useful for inhibiting immune response and treating diseases associated with undesirable immune response.
该发明涉及以下式(I)的化合物:或其盐或溶剂化合物,其中变量如本文所述。式(I)的化合物及其药物组合物是Toll样受体
拮抗剂,如TLR7、TLR8和/或TLR9,可用于抑制免疫反应并治疗与不良免疫反应相关的疾病。